|
Quotes & Info
|
| CVM > SEC Filings for CVM > Form 8-K on 26-Dec-2012 | All Recent SEC Filings |
26-Dec-2012
Change in Directors or Principal Officers
Officers
On December 18, 2012 the Company's directors approved the issuance of options to
the Company's officers and directors. All options are exercisable at a price of
$0.28 per share. Other information concerning the options follows:
Shares
Issuable
Upon
Exercise of Type of
Name of Officer/Director Options Options Vesting Schedule (1)
Non-qualified Equally and annually over
Maximilian de Clara 1,000,000 stock option 5 years
Non-qualified Equally and annually over
Geert R. Kersten 2,300,000 stock option 5 years
Incentive
Geert R. Kersten 2,700,000 stock option As shown below
Incentive
Eyal Talor, Ph.D. 1,500,000 stock option As shown below
Incentive
Patricia B. Prichep 1,500,000 stock option As shown below
Non-qualified Equally and annually over
Dr. C. Richard Kinsolving 500,000 stock option 5 years
Non-qualified Equally and annually over
Dr. Peter R. Young 500,000 stock option 5 years
Non-qualified Equally and annually over
Alexander G. Esterhazy 500,000 stock option 5 years
|
Vesting Schedule:
Options Date Options are
Name Exercisable First Exercisable
Geert R. Kersten 110,770 12-18-13
110,770 12-18-14
354,090 12-18-15
354,085 12-18-16
354,085 12-18-17
354,085 12-18-18
354,085 12-18-19
354,085 12-18-20
354,085 12-18-21
Eyal Talor, Ph.D. 233,900 12-18-13
233,900 12-18-14
344,067 12-18-15
344,067 12-18-16
344,066 12-18-17
Patricia B. Prichep 233,900 12-18-13
233,900 12-18-14
344,067 12-18-15
344,067 12-18-16
344,066 12-18-17
|
(1) Any options which are not then exercisable will automatically terminate 90 days after the date the option holder voluntarily resigns as an officer, director or employee or in the event the option holder is terminated for cause. For purposes of these options, cause is defined as (i) the failure by the option holder to substantially perform his duties and obligations owed to the Corporation (other than any failure resulting from incapacity due to physical or mental illness); (ii) engaging in misconduct or a breach of fiduciary duty which is, or potentially is, materially injurious to the Corporation; (iii) the commission of a crime which is, or potentially is, materially injurious to the Corporation.
|
|